查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1786563

乳房切片市场：全球产业分析、规模、份额、成长、趋势与预测（2025-2032）

Breast Biopsy Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 198 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research 最近发布了一份关于全球乳房切片设备市场的综合报告，该报告彻底评估了关键市场动态，包括市场驱动因素、趋势、机会和挑战，并对市场结构提供了详细的见解。

关键见解

  • 乳房切片市场规模（2025年）：24.659亿美元
  • 市场预测（2032 年）：35.871 亿美元
  • 全球市场成长率（2025-2032年复合年增长率）：5.5%

乳房切片市场 - 研究范围

乳房切片是一项重要的诊断程序，用于评估可疑的乳房异常，并确认或排除乳癌的存在。操作程序包括芯针活检、真空辅助切片检查和细针穿刺，这些活检均在超音波、立体定位系统和核磁共振成像 (MRI) 等显像模式的引导下进行。市场为医院、诊断中心和门诊手术中心提供从针吸活检设备到先进影像导引系统等各种设备。市场成长的驱动力包括：全球乳癌发生率的上升、人们对早期癌症检测意识的增强，以及减少患者不适和缩短恢復时间的微创手术的普及。

市场成长动力：

全球乳房切片市场受乳癌是全球女性癌症相关死亡的主要原因之一。对常规筛检和早期诊断的日益重视，推动了对精准微创切片检查技术的需求。即时3D影像和机器人辅助切片检查设备等技术进步正在提高诊断准确性和操作效率，进一步推动市场成长。此外，已开发经济体和新兴经济体政府纷纷推出支持乳癌认知和筛检计画的倡议，也促进了乳房切片市场的广泛应用。

市场限制：

儘管乳房切片市场成长势头强劲，但仍面临着许多挑战，例如高昂的手术费用以及低收入地区取得乳房切片服务的管道受限。某些切片检查程序的侵入性以及患者对流程的焦虑可能会阻碍其普及，尤其是在医疗基础设施有限的地区。此外，监管部门对新型切片检查系统的严格核准以及对某些程序假阴性结果的担忧，可能会影响市场信心，并减缓先进技术的普及。解决这些问题需要整个产业专注于创新、可负担性和病患教育。

市场机会：

乳房切片市场蕴藏着丰厚的机会，这得益于人工智慧辅助诊断、智慧成像系统以及适用于偏远和资源匮乏环境的携带式切片检查设备等技术的整合。私人和公共医疗机构不断扩大对癌症治疗基础设施的投资，尤其是在亚太地区和拉丁美洲，正在开闢新的成长途径。此外，门诊和家庭诊断的趋势预计将推动对紧凑易用的切片检查系统的需求。与医疗保健提供者、研究机构和数位健康平台建立策略合作伙伴关係，可以增强产品供应并提高市场渗透率。

本报告探讨的关键问题

  • 推动全球乳房切片市场成长的关键因素有哪些？
  • 在不同的临床环境下，哪种切片检查类型和影像方式是首选？
  • 诊断影像和设备小型化的技术进步如何改变市场格局？
  • 乳房切片市场的主要企业是谁？他们正在采取哪些策略措施？
  • 哪些新兴趋势和机会将决定乳房切片技术的未来？

目录

第一章执行摘要

第二章 市场概述

  • 市场范围和定义
  • 价值链分析
  • 宏观经济因素
    • 世界GDP展望
    • 世界GDP展望
    • 全球经济成长预测
    • 全球都市化进程
    • 其他宏观经济因素
  • 预测因子－相关性和影响力
  • COVID-19影响评估
  • PESTLE分析
  • 波特五力分析
  • 地缘政治紧张局势：市场影响
  • 监管和技术格局

第三章 市场动态

  • 驱动程式
  • 抑制因素
  • 机会
  • 趋势

第四章 2019-2032年价格趋势分析

  • 区域价格分析
  • 按细分市场定价
  • 价格影响因素

第五章。全球乳房切片市场展望：实际（2019-2024 年）和预测（2025-2032 年）

  • 主要亮点
  • 全球乳房切片市场展望：产品
    • 简介/主要发现
    • 2019-2024 年各产品市场规模趋势分析
    • 2025 年至 2032 年按产品分類的当前市场规模预测
      • 切片穿刺针
        • 粗针切片
        • 细吸针
      • MRI导引切片检查系统
      • 超音波引导乳房切片系统
        • 二维（2D）乳房X光摄影超音波扫描系统
        • 3D（3D）B型乳房X光摄影超音波扫描系统
      • 真空辅助装置（VAD）
      • 导管导引线（定位丝）
      • 乳房切片标记物
    • 市场吸引力分析：产品
  • 全球乳房切片市场展望：适应症
    • 简介/主要发现
    • 2019 年至 2024 年按适应症分類的市场规模趋势分析
    • 2025 年至 2032 年按适应症分類的当前市场规模预测
      • 复杂囊肿
      • 固体块
      • 可疑固态肿块（纤维腺瘤）
      • 可疑微钙化
    • 市场吸引力分析：迹象
  • 全球乳房切片市场展望：最终用户
    • 简介/主要发现
    • 2019-2024 年最终用户市场规模趋势分析
    • 2025 年至 2032 年按最终用户分類的当前市场规模预测
      • 医院
      • 专科诊所
      • 门诊手术中心
      • 癌症研究所
    • 市场吸引力分析：最终用户

6. 全球乳房切片市场（按地区）展望

  • 主要亮点
  • 2019-2024年区域市场规模趋势分析
  • 2025 年至 2032 年各地区目前市场规模预测
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：地区

第 7 章。北美乳房切片市场展望：实际（2019-2024 年）和预测（2025-2032 年）

8. 欧洲乳房切片市场展望：实际结果（2019-2024 年）与预测（2025-2032 年）

第九章东亚乳房切片市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 10 章。南亚和大洋洲乳房切片市场展望：实际（2019-2024 年）和预测（2025-2032 年）

第 11 章拉丁美洲乳房切片市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第 12 章。中东和非洲乳房切片市场展望：实际结果（2019-2024 年）和预测（2025-2032 年）

第十三章竞争格局

  • 2025年市场占有率分析
  • 市场结构
    • 竞赛实力图谱
    • 竞争对手仪表板
  • 公司简介
    • Argon Medical
    • Becton Dickinson and Company
    • CR Bard, Inc.
    • Cook Medical Inc.
    • Devicor Medical Products, Inc.
    • F. Hoffmann-La Roche Ltd.,
    • GE Healthcare
    • Hologic, Inc.
    • Leica Biosystems
    • Medax Srl Unipersonale
    • Planmed Oy
    • Scion Medical Technologies, LLC
    • Siemens Healthineers
    • Hikma Pharmaceuticals
    • Incytes

第十四章 附录

  • 调查方法
  • 调查前提
  • 首字母缩写和简称
简介目录
Product Code: PMRREP33464

Persistence Market Research has recently released a comprehensive report on the worldwide market for breast biopsy devices. The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure.

Key Insights:

  • Breast Biopsy Market Size (2025E): USD 2,465.9 Million
  • Projected Market Value (2032F): USD 3,587.1 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 5.5%

Breast Biopsy Market - Report Scope:

Breast biopsy is a critical diagnostic procedure employed to evaluate suspicious breast abnormalities and confirm or rule out the presence of breast cancer. Techniques include core needle biopsy, vacuum-assisted biopsy, and fine needle aspiration, guided by imaging modalities such as ultrasound, stereotactic systems, and MRI. The market serves hospitals, diagnostic centers, and ambulatory surgical centers with devices ranging from needle-based biopsy instruments to advanced imaging-guided systems. Market growth is driven by the rising global incidence of breast cancer, increased awareness about early cancer detection, and the adoption of minimally invasive procedures that reduce patient discomfort and recovery time.

Market Growth Drivers:

The global breast biopsy market is propelled by the rising prevalence of breast cancer, one of the leading causes of cancer-related deaths among women globally. Increased emphasis on routine screening and early diagnosis has boosted the demand for accurate and minimally invasive biopsy techniques. Technological advancements, including real-time 3D imaging and robotic-assisted biopsy devices, enhance diagnostic accuracy and procedural efficiency, further driving market growth. Additionally, government initiatives supporting breast cancer awareness and screening programs in both developed and emerging economies contribute to broader market adoption.

Market Restraints:

Despite its strong growth trajectory, the breast biopsy market faces challenges such as high procedural costs and limited accessibility in low-income regions. Invasive nature of some biopsy procedures and patient anxiety regarding the process can hinder adoption, particularly in settings with limited healthcare infrastructure. Moreover, stringent regulatory approvals for new biopsy systems and concerns regarding false-negative results in certain techniques may impact market confidence and slow adoption of advanced technologies. Addressing these issues requires industry-wide focus on innovation, affordability, and patient education.

Market Opportunities:

The breast biopsy market presents lucrative opportunities through technological integration, such as AI-based diagnostic support tools, smart imaging systems, and portable biopsy devices for use in remote and resource-constrained settings. Expanding private and public healthcare investments in cancer care infrastructure, especially in Asia Pacific and Latin America, opens new growth avenues. Furthermore, the trend toward outpatient and home-based diagnostic procedures is expected to stimulate demand for compact and user-friendly biopsy systems. Strategic collaborations with healthcare providers, research institutions, and digital health platforms can enhance product offerings and increase market penetration.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the breast biopsy market globally?
  • Which biopsy types and imaging modalities are preferred across various clinical settings?
  • How are innovations in imaging and device miniaturization reshaping the market landscape?
  • Who are the key players in the breast biopsy market, and what strategic initiatives are they pursuing?
  • What emerging trends and opportunities are expected to define the future of breast biopsy technologies?

Competitive Intelligence and Business Strategy:

These companies invest heavily in R\&D to develop next-generation biopsy tools with enhanced precision, speed, and patient comfort. Collaborative efforts with imaging solution providers and research hospitals aim to integrate AI and machine learning for improved diagnostic outcomes. Market leaders also focus on regulatory approvals, clinical validation, and physician training programs to drive adoption and maintain competitive advantage.

Key Companies Profiled:

  • Argon Medical Devices
  • Becton Dickinson and Company
  • C. R. Bard, Inc.
  • Cook Medical Inc.
  • Devicor Medical Products, Inc.
  • F. Hoffmann-La Roche Ltd.
  • GE Healthcare
  • Hologic, Inc.
  • Leica Biosystems
  • Medax Srl Unipersonale
  • Planmed Oy
  • Scion Medical Technologies, LLC
  • Siemens Healthineer

Breast Biopsy Market Research Segmentation:

Product:

  • Biopsy Needles
    • * Core Needles
    • * Fine Aspiration Needles
  • MRI-Guide Biopsy Systems
  • Ultrasound Guided Breast Biopsy Systems
    • * Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
    • * Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
  • Vacuum-Assisted Devices (VAD)
  • Guide Wire (Localization Wire)
  • Breast Biopsy Markers

Indication:

  • Complex Cysts
  • Solid Mass
  • Suspicious Solid Mass (Fibroadenoma)
  • Suspicious Micro-calcifications

End User:

  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Cancer Research Institutes

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Table of Contents

1. Executive Summary

  • 1.1. Global Breast Biopsy Market Snapshot 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Industry Developments and Key Market Events
  • 1.5. Demand Side and Supply Side Analysis
  • 1.6. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definitions
  • 2.2. Value Chain Analysis
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global GDP Outlook
    • 2.3.2. Global GDP Outlook
    • 2.3.3. Global economic Growth Forecast
    • 2.3.4. Global Urbanization Growth
    • 2.3.5. Other Macro-economic Factors
  • 2.4. Forecast Factors - Relevance and Impact
  • 2.5. COVID-19 Impact Assessment
  • 2.6. PESTLE Analysis
  • 2.7. Porter's Five Forces Analysis
  • 2.8. Geopolitical Tensions: Market Impact
  • 2.9. Regulatory and Technology Landscape

3. Market Dynamics

  • 3.1. Drivers
  • 3.2. Restraints
  • 3.3. Opportunities
  • 3.4. Trends

4. Price Trend Analysis, 2019-2032

  • 4.1. Region-wise Price Analysis
  • 4.2. Price by Segments
  • 4.3. Price Impact Factors

5. Global Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 5.1. Key Highlights
  • 5.2. Global Breast Biopsy Market Outlook: Product
    • 5.2.1. Introduction/Key Findings
    • 5.2.2. Historical Market Size (US$ Mn) Analysis by Product, 2019-2024
    • 5.2.3. Current Market Size (US$ Mn) Forecast, by Product, 2025-2032
      • 5.2.3.1. Biopsy Needles
        • 5.2.3.1.1. Core Needles
        • 5.2.3.1.2. Fine Aspiration Needles
      • 5.2.3.2. MRI-Guide Biopsy Systems
      • 5.2.3.3. Ultrasound Guided Breast Biopsy Systems
        • 5.2.3.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
        • 5.2.3.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
      • 5.2.3.4. Vacuum-Assisted Devices (VAD)
      • 5.2.3.5. Guide Wire (Localization Wire)
      • 5.2.3.6. Breast Biopsy Markers
    • 5.2.4. Market Attractiveness Analysis: Product
  • 5.3. Global Breast Biopsy Market Outlook: Indication
    • 5.3.1. Introduction/Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) Analysis by Indication, 2019-2024
    • 5.3.3. Current Market Size (US$ Mn) Forecast, by Indication, 2025-2032
      • 5.3.3.1. Complex Cysts
      • 5.3.3.2. Solid Mass
      • 5.3.3.3. Suspicious Solid Mass (Fibroadenoma)
      • 5.3.3.4. Suspicious Micro-calcifications
    • 5.3.4. Market Attractiveness Analysis: Indication
  • 5.4. Global Breast Biopsy Market Outlook: End User
    • 5.4.1. Introduction/Key Findings
    • 5.4.2. Historical Market Size (US$ Mn) Analysis by End User, 2019-2024
    • 5.4.3. Current Market Size (US$ Mn) Forecast, by End User, 2025-2032
      • 5.4.3.1. Hospitals
      • 5.4.3.2. Specialty Clinics
      • 5.4.3.3. Ambulatory Surgical Centers
      • 5.4.3.4. Cancer Research Institutes
    • 5.4.4. Market Attractiveness Analysis: End User

6. Global Breast Biopsy Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis by Region, 2019-2024
  • 6.3. Current Market Size (US$ Mn) Forecast, by Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia & Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 7.1. Key Highlights
  • 7.2. Pricing Analysis
  • 7.3. North America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. North America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 7.4.1. Biopsy Needles
      • 7.4.1.1. Core Needles
      • 7.4.1.2. Fine Aspiration Needles
    • 7.4.2. MRI-Guide Biopsy Systems
    • 7.4.3. Ultrasound Guided Breast Biopsy Systems
      • 7.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 7.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 7.4.4. Vacuum-Assisted Devices (VAD)
    • 7.4.5. Guide Wire (Localization Wire)
    • 7.4.6. Breast Biopsy Markers
  • 7.5. North America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 7.5.1. Complex Cysts
    • 7.5.2. Solid Mass
    • 7.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 7.5.4. Suspicious Micro-calcifications
  • 7.6. North America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 7.6.1. Hospitals
    • 7.6.2. Specialty Clinics
    • 7.6.3. Ambulatory Surgical Centers
    • 7.6.4. Cancer Research Institutes

8. Europe Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 8.1. Key Highlights
  • 8.2. Pricing Analysis
  • 8.3. Europe Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. Italy
    • 8.3.3. France
    • 8.3.4. U.K.
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Rest of Europe
  • 8.4. Europe Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 8.4.1. Biopsy Needles
      • 8.4.1.1. Core Needles
      • 8.4.1.2. Fine Aspiration Needles
    • 8.4.2. MRI-Guide Biopsy Systems
    • 8.4.3. Ultrasound Guided Breast Biopsy Systems
      • 8.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 8.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 8.4.4. Vacuum-Assisted Devices (VAD)
    • 8.4.5. Guide Wire (Localization Wire)
    • 8.4.6. Breast Biopsy Markers
  • 8.5. Europe Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 8.5.1. Complex Cysts
    • 8.5.2. Solid Mass
    • 8.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 8.5.4. Suspicious Micro-calcifications
  • 8.6. Europe Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 8.6.1. Hospitals
    • 8.6.2. Specialty Clinics
    • 8.6.3. Ambulatory Surgical Centers
    • 8.6.4. Cancer Research Institutes

9. East Asia Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 9.1. Key Highlights
  • 9.2. Pricing Analysis
  • 9.3. East Asia Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. East Asia Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 9.4.1. Biopsy Needles
      • 9.4.1.1. Core Needles
      • 9.4.1.2. Fine Aspiration Needles
    • 9.4.2. MRI-Guide Biopsy Systems
    • 9.4.3. Ultrasound Guided Breast Biopsy Systems
      • 9.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 9.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 9.4.4. Vacuum-Assisted Devices (VAD)
    • 9.4.5. Guide Wire (Localization Wire)
    • 9.4.6. Breast Biopsy Markers
  • 9.5. East Asia Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 9.5.1. Complex Cysts
    • 9.5.2. Solid Mass
    • 9.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 9.5.4. Suspicious Micro-calcifications
  • 9.6. East Asia Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 9.6.1. Hospitals
    • 9.6.2. Specialty Clinics
    • 9.6.3. Ambulatory Surgical Centers
    • 9.6.4. Cancer Research Institutes

10. South Asia & Oceania Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 10.1. Key Highlights
  • 10.2. Pricing Analysis
  • 10.3. South Asia & Oceania Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of SAO
  • 10.4. South Asia & Oceania Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 10.4.1. Biopsy Needles
      • 10.4.1.1. Core Needles
      • 10.4.1.2. Fine Aspiration Needles
    • 10.4.2. MRI-Guide Biopsy Systems
    • 10.4.3. Ultrasound Guided Breast Biopsy Systems
      • 10.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 10.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 10.4.4. Vacuum-Assisted Devices (VAD)
    • 10.4.5. Guide Wire (Localization Wire)
    • 10.4.6. Breast Biopsy Markers
  • 10.5. South Asia & Oceania Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 10.5.1. Complex Cysts
    • 10.5.2. Solid Mass
    • 10.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 10.5.4. Suspicious Micro-calcifications
  • 10.6. South Asia & Oceania Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 10.6.1. Hospitals
    • 10.6.2. Specialty Clinics
    • 10.6.3. Ambulatory Surgical Centers
    • 10.6.4. Cancer Research Institutes

11. Latin America Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 11.1. Key Highlights
  • 11.2. Pricing Analysis
  • 11.3. Latin America Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of LATAM
  • 11.4. Latin America Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 11.4.1. Biopsy Needles
      • 11.4.1.1. Core Needles
      • 11.4.1.2. Fine Aspiration Needles
    • 11.4.2. MRI-Guide Biopsy Systems
    • 11.4.3. Ultrasound Guided Breast Biopsy Systems
      • 11.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 11.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 11.4.4. Vacuum-Assisted Devices (VAD)
    • 11.4.5. Guide Wire (Localization Wire)
    • 11.4.6. Breast Biopsy Markers
  • 11.5. Latin America Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 11.5.1. Complex Cysts
    • 11.5.2. Solid Mass
    • 11.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 11.5.4. Suspicious Micro-calcifications
  • 11.6. Latin America Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 11.6.1. Hospitals
    • 11.6.2. Specialty Clinics
    • 11.6.3. Ambulatory Surgical Centers
    • 11.6.4. Cancer Research Institutes

12. Middle East & Africa Breast Biopsy Market Outlook: Historical (2019-2024) and Forecast (2025-2032)

  • 12.1. Key Highlights
  • 12.2. Pricing Analysis
  • 12.3. Middle East & Africa Market Size (US$ Mn) Forecast, by Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. South Africa
    • 12.3.3. Northern Africa
    • 12.3.4. Rest of MEA
  • 12.4. Middle East & Africa Market Size (US$ Mn) Forecast, by Product, 2025-2032
    • 12.4.1. Biopsy Needles
      • 12.4.1.1. Core Needles
      • 12.4.1.2. Fine Aspiration Needles
    • 12.4.2. MRI-Guide Biopsy Systems
    • 12.4.3. Ultrasound Guided Breast Biopsy Systems
      • 12.4.3.1. Two-Dimensional (2D) Mammographic Ultrasonic Scanning Systems
      • 12.4.3.2. Three-Dimensional (3D) B-Mode Mammographic Ultrasonic Scanning Systems
    • 12.4.4. Vacuum-Assisted Devices (VAD)
    • 12.4.5. Guide Wire (Localization Wire)
    • 12.4.6. Breast Biopsy Markers
  • 12.5. Middle East & Africa Market Size (US$ Mn) Forecast, by Indication, 2025-2032
    • 12.5.1. Complex Cysts
    • 12.5.2. Solid Mass
    • 12.5.3. Suspicious Solid Mass (Fibroadenoma)
    • 12.5.4. Suspicious Micro-calcifications
  • 12.6. Middle East & Africa Market Size (US$ Mn) Forecast, by End User, 2025-2032
    • 12.6.1. Hospitals
    • 12.6.2. Specialty Clinics
    • 12.6.3. Ambulatory Surgical Centers
    • 12.6.4. Cancer Research Institutes

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles
    • 13.3.1. Argon Medical
      • 13.3.1.1. Company Overview
      • 13.3.1.2. Product Portfolio/Offerings
      • 13.3.1.3. Key Financials
      • 13.3.1.4. SWOT Analysis
      • 13.3.1.5. Company Strategy and Key Developments
    • 13.3.2. Becton Dickinson and Company
    • 13.3.3. C.R. Bard, Inc.
    • 13.3.4. Cook Medical Inc.
    • 13.3.5. Devicor Medical Products, Inc.
    • 13.3.6. F. Hoffmann-La Roche Ltd.,
    • 13.3.7. GE Healthcare
    • 13.3.8. Hologic, Inc.
    • 13.3.9. Leica Biosystems
    • 13.3.10. Medax Srl Unipersonale
    • 13.3.11. Planmed Oy
    • 13.3.12. Scion Medical Technologies, LLC
    • 13.3.13. Siemens Healthineers
    • 13.3.14. Hikma Pharmaceuticals
    • 13.3.15. Incytes

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations